← back to search

Chaim A. Schramm

Columbia University · US
Area of research
Virology · Immunology
Research interest
Research interests include Biology, Virology, Antibody, Neutralization, Human immunodeficiency virus (HIV), and Computer science.
h-index
citations
3,496
works
15
NIH funding
primary concept
email

Recent publications

Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaques
Science Translational Medicine 2025cited by 4position: middledoi
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
Science 2024cited by 37position: middledoi
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
Cell 2024cited by 28position: middledoi
Adaptive Immune Receptor Repertoire (AIRR) Community Guide to TR and IG Gene Annotation
Methods in molecular biology 2022cited by 5position: middledoi
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth
Science 2020cited by 99position: middledoi
The ADC API: A Web API for the Programmatic Query of the AIRR Data Commons
Frontiers in Big Data 2020cited by 43position: middledoi
Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for Their Evaluation, Documentation, and Naming
Frontiers in Immunology 2019cited by 73position: middledoi
AIRR Community Standardized Representations for Annotated Immune Repertoires
Frontiers in Immunology 2018cited by 100position: middledoi
Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data
Frontiers in Immunology 2017cited by 113position: middledoi
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Immunity 2016cited by 392position: middledoi
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
Cell 2016cited by 332position: middledoi
The Membrane- and Soluble-Protein Helix-Helix Interactome: Similar Geometry via Different Interactions
Structure 2015cited by 85position: middledoi
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nature 2014cited by 749position: middledoi
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Nature 2013cited by 1,051position: middledoi
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
Immunity 2013cited by 385position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian E. Busse · German Cancer Research Center5 papers (2017–2022)Corey T. Watson · Centre for Human Genetics4 papers (2017–2022)Scott Christley · Southwestern Medical Center4 papers (2017–2020)Steven H. Kleinstein · Yale University3 papers (2017–2019)F. A. Matsen · Howard Hughes Medical Institute3 papers (2017–2019) · 3 papers (2017–2020)Uri Laserson · Ginkgo Bioworks, Inc. (United States)3 papers (2017–2020)Brian Corrie · Simon Fraser University2 papers (2018–2020)Jamie K. Scott · The University of Texas Southwestern Medical Center2 papers (2017–2019)Marie‐Paule Lefranc · Centre National de la Recherche Scientifique2 papers (2017–2019)Aaron M. Rosenfeld · Natera (United States)2 papers (2018–2022) · 2 papers (2017–2020)Susanna Marquez · Yale University2 papers (2018–2022) · 2 papers (2018–2019)Lindsay G. Cowell · Southwestern Medical Center2 papers (2017–2020)Mats Ohlin · Lund University2 papers (2019–2022) · 2 papers (2018–2020)William Lees · University of London2 papers (2019–2022) · 2 papers (2018–2019)Andrew M. Collins · UNSW Sydney2 papers (2017–2019)